MedX Health Corp (TSXV: MDX)
Canada
· Delayed Price · Currency is CAD 0.0700
0.00 (0.00%)
Dec 20, 2024, 9:30 AM EST
MedX Health Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 0.37 | 0.46 | 0.51 | 0.56 | 0.53 | 0.86 | Upgrade
|
| Revenue Growth (YoY) | -38.93% | -10.68% | -9.32% | 6.23% | -38.38% | -20.89% | Upgrade
|
| Cost of Revenue | 0.24 | 0.27 | 0.27 | 0.29 | 0.26 | 0.38 | Upgrade
|
| Gross Profit | 0.12 | 0.19 | 0.24 | 0.27 | 0.27 | 0.48 | Upgrade
|
| Selling, General & Admin | 2.21 | 2.62 | 3.43 | 3.84 | 2.79 | 2.17 | Upgrade
|
| Research & Development | 0.52 | 0.59 | 0.68 | 1 | 0.43 | 0.54 | Upgrade
|
| Operating Expenses | 2.73 | 3.21 | 4.11 | 4.84 | 3.3 | 3.61 | Upgrade
|
| Operating Income | -2.6 | -3.03 | -3.87 | -4.56 | -3.03 | -3.13 | Upgrade
|
| Interest Expense | -1.14 | -2.15 | -1.27 | -0.78 | -0.06 | -0.13 | Upgrade
|
| Currency Exchange Gain (Loss) | -0 | -0 | 0 | -0.01 | -0.01 | -0.02 | Upgrade
|
| EBT Excluding Unusual Items | -3.75 | -5.18 | -5.13 | -5.35 | -3.1 | -3.28 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.6 | 0.6 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | 0.02 | -0.1 | - | Upgrade
|
| Pretax Income | -3.15 | -4.58 | -5.13 | -5.32 | -3.2 | -3.28 | Upgrade
|
| Net Income | -3.15 | -4.58 | -5.13 | -5.32 | -3.2 | -3.28 | Upgrade
|
| Net Income to Common | -3.15 | -4.58 | -5.13 | -5.32 | -3.2 | -3.28 | Upgrade
|
| Shares Outstanding (Basic) | 257 | 197 | 184 | 180 | 167 | 140 | Upgrade
|
| Shares Outstanding (Diluted) | 257 | 197 | 184 | 180 | 167 | 140 | Upgrade
|
| Shares Change (YoY) | 39.38% | 7.06% | 1.97% | 8.18% | 18.81% | 7.55% | Upgrade
|
| EPS (Basic) | -0.01 | -0.02 | -0.03 | -0.03 | -0.02 | -0.02 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.02 | -0.03 | -0.03 | -0.02 | -0.02 | Upgrade
|
| Free Cash Flow | -2.53 | -3.42 | -2.8 | -4.53 | -2.91 | -1.33 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.02 | -0.02 | -0.03 | -0.02 | -0.01 | Upgrade
|
| Gross Margin | 33.47% | 40.70% | 46.99% | 48.54% | 50.58% | 55.78% | Upgrade
|
| Operating Margin | -707.53% | -663.25% | -757.61% | -810.29% | -571.52% | -363.90% | Upgrade
|
| Profit Margin | -855.63% | -1004.31% | -1005.41% | -945.40% | -603.60% | -380.86% | Upgrade
|
| Free Cash Flow Margin | -687.05% | -750.32% | -548.53% | -805.04% | -549.81% | -154.52% | Upgrade
|
| EBITDA | -2.62 | -3.02 | -3.86 | -4.55 | -2.99 | -3.03 | Upgrade
|
| D&A For EBITDA | -0.01 | 0.01 | 0.01 | 0.01 | 0.04 | 0.1 | Upgrade
|
| EBIT | -2.6 | -3.03 | -3.87 | -4.56 | -3.03 | -3.13 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.